• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTACT VASCULAR, INC. TACK ENDOVASCULAR SYSTEM (6F, 3.5-6.0MM); SCAFFOLD, DISSECTION REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTACT VASCULAR, INC. TACK ENDOVASCULAR SYSTEM (6F, 3.5-6.0MM); SCAFFOLD, DISSECTION REPAIR Back to Search Results
Catalog Number 156120061
Device Problem Insufficient Information (3190)
Patient Problem Thrombus (2101)
Event Type  Injury  
Manufacturer Narrative
The device has not been returned to intact vascular at the time of this report and is not expected to be returned.Intact vascular has attempted to contact the reporter of this event for additional information.If additional information is received after this report, a supplemental report will be submitted.
 
Event Description
The patient underwent endovascular procedure on (b)(6) 2020.Tack endovascular system (6f, 3.5-6.0mm) was used to treat dissections observed.Displacement of the deployed tack implant(s) was observed.During the index procedure on (b)(6) 2020, the physician deployed three tack implants in right superior femoral artery (sfa) and followed post dilatation of the tack implants, displacement of the tack implant(s) was observed by the physician.The physician then proceeded to deploy eluvia des within the sfa and observed additional tack implant(s) displacement.Unsuccessful attempts were made by the physician to snare the displaced tack implants.The physician completed the procedure by performing another post dilatation step.The conclusion of the index procedure, had the tack implant(s) displaced from mid-sfa to p1 region, angiography demonstrated good blood flow.The physician documented required patient follow-up with ultrasound.Patient ultrasound was taken, and the physician decided to re-intervene based on the results of the ultrasound on (b)(6) 2020.The re-intervention included use of jetstream atherectomy followed by prolonged angioplasty near the tack implanted region.The conclusion of the (b)(6) 2020 procedure, had the physician recommending the patient to vascular surgeon for surgical removal of the tack implant(s).Intact vascular representative was made aware of the incident on (b)(6) 2020.Vascular surgeon dr.Baljeet uppal of the banner boswell medical center performed embolectomy and endarterectomy of the right popliteal artery, tibio-peroneal trunk proximal tibial and peroneal artery on (b)(6) 2020 and explanted at least one of the tack implant(s).The surgical intervention concluded with patient receiving successful revascularization of the right lower extremity and patient remained hemodynamically stable throughout.
 
Manufacturer Narrative
The device has not been returned to intact vascular at the time of this report and is not expected to be returned.Intact vascular has attempted to contact the reporter of this event for additional information.If additional information is received after this report, a supplemental report will be submitted.
 
Event Description
The patient underwent endovascular procedure on (b)(6) 2020.Tack endovascular system (6f, 3.5-6.0mm) was used to treat dissections observed.Displacement of the deployed tack implant(s) was observed.During the index procedure on (b)(6) 2020, the physician deployed three tack implants in right superior femoral artery (sfa) and followed post dilatation of the tack implants, displacement of the tack implant(s) was observed by the physician.The physician then proceeded to deploy eluvia des within the sfa and observed additional tack implant(s) displacement.Unsuccessful attempts were made by the physician to snare the displaced tack implants.The physician completed the procedure by performing another post dilatation step.The conclusion of the index procedure, had the tack implant(s) displaced from mid-sfa to p1 region, angiography demonstrated good blood flow.The physician documented required patient follow-up with ultrasound.Patient ultrasound was taken, and the physician decided to re-intervene based on the results of the ultrasound on (b)(6) 2020.The re-intervention included use of jetstream atherectomy followed by prolonged angioplasty near the tack implanted region.The conclusion of the (b)(6) 2020 procedure, had the physician recommending the patient to vascular surgeon for surgical removal of the tack implant(s).Intact vascular representative was made aware of the incident on (b)(6) 2020.Vascular surgeon dr.Baljeet uppal of (b)(6) performed embolectomy and endarterectomy of the right popliteal artery, tibio-peroneal trunk proximal tibial and peroneal artery on (b)(6) 2020 and explanted at least one of the tack implant(s).The surgical intervention concluded with patient receiving successful revascularization of the right lower extremity and patient remained hemodynamically stable throughout.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACK ENDOVASCULAR SYSTEM (6F, 3.5-6.0MM)
Type of Device
SCAFFOLD, DISSECTION REPAIR
Manufacturer (Section D)
INTACT VASCULAR, INC.
1285 drummers lane
suite 200
wayne, pa
MDR Report Key10093192
MDR Text Key194996233
Report Number3012608866-2020-00002
Device Sequence Number1
Product Code QCT
UDI-Device Identifier00863328000103
UDI-Public00863328000103
Combination Product (y/n)N
PMA/PMN Number
P180034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number156120061
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/28/2020
Initial Date FDA Received05/27/2020
Supplement Dates Manufacturer Received04/28/2020
Supplement Dates FDA Received05/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age84 YR
-
-